Literature DB >> 12595910

Dehydroepiandrosterone (DHEA) and the aging brain: flipping a coin in the "fountain of youth".

Marco Racchi1, Carla Balduzzi, Emanuela Corsini.   

Abstract

The physiological role of dehydroepiandrosterone (DHEA) and its sulphated ester DHEA(S) has been studied for nearly 2 decades and still eludes final clarification. The major interest in DHEA derives from its unique pattern of activity. Its levels exhibit a dramatic age-related decline that supports significant involvement of DHEA(S) in the aging process. Particularly relevant to the aging process is the functional decline that involves memory and cognitive abilities. DHEA is derived mainly from synthesis in the adrenal glands and gonads. It can also be detected in the brain where it is derived from a synthesis that is independent from peripheral steroid sources. For this reason DHEA and other steroid molecules have been named "neurosteroids." Pharmacological studies on animals provided evidence that neurosteroids could be involved in learning and memory processes because they can display memory-enhancing properties in aged rodents. However, human studies have reported contradictory results that so far do not directly support the use of DHEA in aging-related conditions. As such, it is important to remember that plasma levels of DHEA(S) may not reflect levels in the central nervous system (CNS), due to intrinsic ability of the brain to produce neurosteroids. Thus, the importance of neurosteroids in the memory process and in age-related cognitive impairment should not be dismissed. Furthermore, the fact that the compound is sold in most countries as a health food supplement is hampering the rigorous scientific evaluation of its potential. We will describe the effect of neurosteroids, in particular DHEA, on neurochemical mechanism involved in memory and learning. We will focus on a novel effect on a signal transduction mechanism involving a classical "cognitive kinase" such as protein kinase C. The final objective is to provide additional tools to understand the physiological role and therapeutic potentials of neurosteroids in normal and/or pathological aging, such as Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12595910      PMCID: PMC6741703          DOI: 10.1111/j.1527-3458.2003.tb00242.x

Source DB:  PubMed          Journal:  CNS Drug Rev        ISSN: 1080-563X


  8 in total

1.  Sigma receptors [σRs]: biology in normal and diseased states.

Authors:  Colin G Rousseaux; Stephanie F Greene
Journal:  J Recept Signal Transduct Res       Date:  2015-06-09       Impact factor: 2.092

Review 2.  Dehydroepiandrosterone and age-related cognitive decline.

Authors:  Krystina G Sorwell; Henryk F Urbanski
Journal:  Age (Dordr)       Date:  2009-08-27

3.  Stimulation of oxidative energy metabolism in liver mitochondria from old and young rats by treatment with dehydroepiandrosterone (DHEA). A comparative study.

Authors:  Minal A Patel; Hiren R Modi; Surendra S Katyare
Journal:  Age (Dordr)       Date:  2007-02-15

4.  Role of androgens in dhea-induced rack1 expression and cytokine modulation in monocytes.

Authors:  Emanuela Corsini; Valentina Galbiati; Angela Papale; Elena Kummer; Antonella Pinto; Melania M Serafini; Antonio Guaita; Roberto Spezzano; Donatella Caruso; Marina Marinovich; Marco Racchi
Journal:  Immun Ageing       Date:  2016-05-29       Impact factor: 6.400

5.  Gender differences in the relationships among neurosteroid serum levels, cognitive function, and quality of life.

Authors:  Chien-Yu Chen; Chih-Ching Wu; Yu-Chi Huang; Chi-Fa Hung; Liang-Jen Wang
Journal:  Neuropsychiatr Dis Treat       Date:  2018-09-19       Impact factor: 2.570

6.  Dehydroepiandrosterone (DHEA) Sensitizes Irinotecan to Suppress Head and Neck Cancer Stem-Like Cells by Downregulation of WNT Signaling.

Authors:  Li-Jie Li; Chien-Hsiu Li; Peter Mu-Hsin Chang; Tsung-Ching Lai; Chen-Yin Yong; Sheng-Wei Feng; Michael Hsiao; Wei-Min Chang; Chi-Ying F Huang
Journal:  Front Oncol       Date:  2022-07-13       Impact factor: 5.738

7.  Effects of endocrine disruptors on dehydroepiandrosterone sulfotransferase and enzymes involved in PAPS synthesis: genomic and nongenomic pathways.

Authors:  Robert Harris; Nahid Turan; Christopher Kirk; David Ramsden; Rosemary Waring
Journal:  Environ Health Perspect       Date:  2007-12       Impact factor: 9.031

Review 8.  The Utilization of Dehydroepiandrosterone as a Sexual Hormone Precursor in Premenopausal and Postmenopausal Women: An Overview.

Authors:  Justine Tang; Li-Ru Chen; Kuo-Hu Chen
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.